Zalicus: Ridiculously Cheap - Seeking Alpha

Zalicus: Ridiculously Cheap Seeking Alpha Zacks anticipates management will progress Synavive into a phase II program in rheumatoid arthritis in 2011. If successfully commercialized, Synavive should ...

Protalex, Inc. Announces Dose Escalation of First Patients in 2nd Cohort of ... - MarketWatch (press release)

Protalex, Inc. Announces Dose Escalation of First Patients in 2nd Cohort of ... MarketWatch (press release) ... of its ongoing multicenter Phase 1b clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA) being conducted in South Africa. ... and more »

Mind and Body - Joint effort! - The Hindu

The Hindu

Mind and Body - Joint effort! The Hindu There are many types of arthritis — osteoarthritis, rheumatoid arthritis, fibromyalgia, systemic lupus erythematosus, scleroderma, juvenile rheumatoid ...

NHS needs more data on rheumatoid arthritis drug - WebMD.Boots.com

NHS needs more data on rheumatoid arthritis drug WebMD.Boots.com Golimumab is a new treatment for moderate to severe active rheumatoid arthritis where the response to disease-modifying anti-rheumatic drug (DMARD) therapy ... CORRECT: NICE Not Minded To OK Merck's Simponi, Wants More DataWall Street Journal UK NICE Appraisal Consultation on Merck & Co's Simponi for rheumatoid ...The Pharma Letter (subscription) all 8 news articles »